CLINICAL_TRIALS
trial_result
· 2020-03-24
Clinical Trial Update: A Study of the Effect of Dalcetrapib on Artherosclerotic Disease in Patients With Coronary Artery Disease [Phase 3]
Summary
Phase 3 trial of dalcetrapib in patients with coronary artery disease was terminated; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hoffmann-La Roche | Conditions: Cardiovascular Disease | Phase 3 | Status: TERMINATED | Results posted: 2020-03-24